Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
The Lancet infectious diseases, 2023-03, Vol.23 (3), p.280-281 [Peer Reviewed Journal]2023 Elsevier Ltd ;2023. Elsevier Ltd ;2023 Elsevier Ltd. All rights reserved. 2023 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00051-8 ;PMID: 36736338
Full text available